|
|
¿À½ºÅÛÀÓÇöõÆ®, ¾Æ½Ã¾Æ ÃÖ°í¿¡¼ ±Û·Î¹ú ÃÖ°í¸¦ ÇâÇØ |
¹Úº´¿ì ±âÀÚ |
2022-11-16 07:48 |
Á¦¾à/¹ÙÀÌ¿À Weekly-ÇÑÈÅõÀÚÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2022-11-14 16:50 |
Çѱ¹Äݸ¶, ¿¹»ó ¹üÀ§ ³»ÀÇ 3ºÐ±â ºÎÁø, ±â´ëµÇ´Â ±× ÀÌÈÄ |
±è»ç¶û ±âÀÚ |
2022-11-14 16:21 |
¾¾Á¨, ÀÏȸ¼º ºñ¿ëÀ¸·Î ÀÎÇÑ ¾î´× ¼îÅ© |
¹Úº´¿ì ±âÀÚ |
2022-11-14 16:16 |
JWÁß¿ÜÁ¦¾à, 3Q22 Review: Àúµµ ´ä´äÇÏÁö¸¸ ¿¬°£À¸·Î º¾´Ï´Ù |
¹Úº´¿ì ±âÀÚ |
2022-11-11 15:03 |
¶óÀÎ |
Biosimilar Industry Update: ÁÖ¿ä ±â¾÷ 3ºÐ±â ½ÇÀû update |
±è»ç¶û ±âÀÚ |
2022-11-11 09:31 |
¼¿Æ®¸®¿Â, ¹ÙÀÌ¿À½Ã¹Ð·¯ Áß½ÉÀÇ ¼ºÀåÀ» ½ÃÇöÇÑ 3ºÐ±â |
±è»ç¶û ±âÀÚ |
2022-11-10 15:50 |
°½ºÅÛ¹ÙÀÌ¿ÀÅØ, Á¦´ëÇ÷ À¯·¡ Áٱ⼼Æ÷Ä¡·áÁ¦ Àü¹®±â¾÷ |
¹Úº´¿ì ±âÀÚ |
2022-11-10 08:01 |
ÆĹ̼¿, ¶°¿À¸£´Â »ûº° |
¹Úº´¿ì ±âÀÚ |
2022-11-09 07:54 |
¿¡½ºÆ¼ÆÊ, Á¶±Ý ¸Ö¾îÁø ¹Ì·¡ |
¹Úº´¿ì ±âÀÚ |
2022-11-09 07:47 |
¶óÀÎ |
Á¦¾à/¹ÙÀÌ¿À Weekly-ÇÑÈÅõÀÚÁõ±Ç |
¹Úº´¿ì ±âÀÚ |
2022-11-08 07:48 |
ÀÌÁßÇ×ü Ä¡·áÁ¦ ½ÃÀå°ú ºòÆĸ¶ Àü·« °üÁ¡¿¡¼ º¸´Â ·¹ÀÌÀúƼ´Õ |
¹Úº´¿ì ±âÀÚ |
2022-11-04 09:50 |
À¯ÇѾçÇà, ´Ü±â ½ÇÀûº¸´Ù´Â ÁßÀå±â ¼ºÀåÀ» °ßÀÎÇÒ ½Å¾à ¿¬±¸°á°ú¿¡ ÁÖ¸ñ |
±è»ç¶û ±âÀÚ |
2022-11-04 09:44 |
GC³ì½ÊÀÚ, ºñ±³ ±âÁØÀÌ ³ô¾Æ ¾Æ½¬¿î 3ºÐ±â |
¹Úº´¿ì ±âÀÚ |
2022-11-03 08:09 |
Çѹ̾àÇ°, 2022³â 3ºÐ±â ETC¿Í ºÏ°æÇѹ̰¡ È£½ÇÀû¼¼¸¦ °ßÀÎ |
¹Úº´¿ì ±âÀÚ |
2022-11-03 08:04 |
¶óÀÎ |
SK¹ÙÀÌ¿ÀÆÊ, ÀÚü ½Å¾à°³¹ß, ¹Ì±¹ Á÷ÆÇ: °¡°íÀÚ ÇÏ´Â ±æÀº ¸Â´Ù |
±è»ç¶û ±âÀÚ |
2022-11-02 09:36 |
ȯÀÎÁ¦¾à, 3Q22 Review: ±â´ëÄ¡ »óȸ, 4Q22 ÀÌÈÄ ±â´ë°¨ |
¹Úº´¿ì ±âÀÚ |
2022-11-02 08:27 |
´ë¿õÁ¦¾à, °õÀÇ ÀçÁÖ(¸ÅÃ⠽űâ·Ï °æ½Å) ³Ñ±â´Â °è¼ÓµÈ´Ù |
±è»ç¶û ±âÀÚ |
2022-11-01 17:04 |
HKÀ̳뿣, 3ºÐ±â µ¹°Ý´ëÀåÀº ÄÁµð¼Ç |
±è»ç¶û ±âÀÚ |
2022-11-01 16:58 |
¿¡½ºÆ¼ÆÊ, 3Q22 Review: Á¶±Ý ¸Ö¾îÁø ¹Ì·¡ |
¹Úº´¿ì ±âÀÚ |
2022-11-01 08:55 |
|